IL6 and cancer: Their investigative focus encompassed a suite of biomarkers—activin A, growth differentiation factor 15 (GDF-15), IL-6, interleukin-1 beta (IL-1β), and tumor necrosis factor alpha (TNF-α)—which provided a comprehensive view of cancer cachexia’s unfolding.